scholarly article | Q13442814 |
P356 | DOI | 10.1038/KI.1995.288 |
P698 | PubMed publication ID | 7564083 |
P2093 | author name string | R J Walker | |
M C Robertson | |||
M J Ball | |||
S A Stapley | |||
W H Sutherland | |||
P2860 | cites work | Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins | Q67897493 |
Risk factors for accelerated atherosclerosis in renal transplant recipients | Q68142393 | ||
Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure | Q68174243 | ||
The antioxidant butylated hydroxytoluene protects against atherosclerosis | Q68183264 | ||
Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood | Q69793840 | ||
Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure | Q70181338 | ||
Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation | Q70574095 | ||
Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation | Q70580559 | ||
Thiobarbituric Acid Reactive Material in Uremic Blood | Q71070627 | ||
Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? | Q72473939 | ||
LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers | Q72858488 | ||
Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis | Q72898129 | ||
Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects | Q33891495 | ||
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions | Q34248823 | ||
Effects of ACE inhibitors on oxidation of human low density lipoprotein | Q34345963 | ||
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros | Q34360883 | ||
Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis | Q34620005 | ||
Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant Patients | Q40074815 | ||
Serum lipoprotein abnormalities in renal allograft recipients | Q40164159 | ||
Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoprotein | Q42793021 | ||
Lipid peroxides and atherosclerosis | Q43379861 | ||
Simultaneous determination of α-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography | Q44534536 | ||
Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking | Q45197147 | ||
Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. | Q54231348 | ||
Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification | Q54272815 | ||
Vitamin E content and low density lipoprotein oxidizability induced by free radicals. | Q54326516 | ||
Autoantibody against oxidised LDL and progression of carotid atherosclerosis | Q59704366 | ||
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man | Q67516427 | ||
Low density lipoprotein composition and oxidizability in coronary disease--apparent favourable effect of beta blockers | Q67524940 | ||
Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure | Q67582315 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 227-236 | |
P577 | publication date | 1995-07-01 | |
P1433 | published in | Kidney International | Q6404823 |
P1476 | title | Oxidation of low density lipoproteins from patients with renal failure or renal transplants | |
P478 | volume | 48 |
Q45107476 | A prudent algorithm for hyperlipoproteinemia in renal transplant recipients |
Q73712824 | Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy |
Q73098816 | An hydroalcoholic extract of curcuma longa lowers the apo B/apo A ratio. Implications for atherogenesis prevention |
Q30490221 | Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial. |
Q44491073 | Beneficial effects of fluvastatin on progressive renal allograft dysfunction |
Q57750639 | Cardiovascular disease in renal transplantation: Management by statins |
Q73423970 | Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1 |
Q30490204 | Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study. |
Q46873899 | Effect of calcineurin inhibitors on low-density lipoprotein oxidation |
Q34137545 | Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study |
Q44297695 | Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis |
Q61864856 | Fatty acid composition in low-density lipoproteins from renal transplant recipients |
Q43963171 | Fatty acid composition of low-density lipoprotein in renal transplant recipients treated with cyclosporine. |
Q86978354 | Fluvastatin Decreases Oxidative Stress in Kidney Transplant Patients |
Q77340490 | HDL composition and HDL antioxidant capacity in patients on regular haemodialysis |
Q46865479 | Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions |
Q35764605 | Immunological evidence for hypochlorite-modified proteins in human kidney |
Q37048963 | Lipid Profile In Transplant Patients: A Clinical Study |
Q34348769 | Lipid peroxidation in aging and age-dependent diseases |
Q45958503 | Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus. |
Q41071344 | Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies |
Q50961766 | Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls. |
Q74014108 | Oxidation of low-density lipoprotein and atherosclerosis in chronic renal failure |
Q61864861 | Oxidation of low-density lipoproteins in renal transplant recipients |
Q43963175 | Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus. |
Q33788653 | Oxidized LDL, glomerular mesangial cells and collagen |
Q34310277 | Pathophysiology of oxidative stress in diabetes mellitus |
Q28076119 | Post-transplant dyslipidemia: Mechanisms, diagnosis and management |
Q73487574 | Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients |
Q38298703 | Role of CAGA boxes in the plasminogen activator inhibitor-1 promoter in mediating oxidized low-density lipoprotein-induced transcriptional activation in mesangial cells |
Q47112177 | Status of antioxidant and homocysteine-lowering vitamins related to cardiovascular diseases in hemodialysis patients. |
Q73229423 | Susceptibility of VLDL to oxidation in patients on regular haemodialysis |
Search more.